Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage

被引:12
|
作者
Xu, Hong-Tao [1 ,2 ,3 ]
Xie, Xue-Mei [1 ,2 ,3 ]
Li, Qing-Chang [1 ,2 ,3 ]
Liu, Shu-Li [1 ,2 ,3 ]
Dai, Shun-Dong [1 ,2 ,3 ]
Liu, Yang [1 ,2 ,3 ]
Wang, En-Hua [1 ,2 ,3 ]
机构
[1] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang 110001, Peoples R China
[2] China Med Univ, Coll Basic Med Sci, Shenyang 110001, Peoples R China
[3] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Peoples R China
基金
中国国家自然科学基金;
关键词
Atonal homolog 1; Axin; Disabled-2; chibby; lung cancer; GAMMA-SECRETASE INHIBITOR; COLON-CANCER; BETA-CATENIN; HAIR-CELLS; MATH1; TUMORIGENESIS; HATH1; MEDULLOBLASTOMA; PROLIFERATION; ACTIVATION;
D O I
10.1111/j.1600-0463.2012.02946.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Atonal homolog 1 (Atoh1) is crucial to the differentiation of many cell types and participates in tumorigenesis and progression. This study investigated the role of Atoh1 in lung cancer development and its correlation with key members of the Wnt pathway. We used immunohistochemistry to examine the expressions of Atoh1, beta-catenin, Axin, chibby, and Disabled-2 (Dab2) in 118 samples of lung cancer. We also detected the cytoplasmic and nuclear expression of Atoh1 in lung cancer tissues using western blot. Atoh1 nuclear expression was negatively correlated with differentiation level (p=0.004) and primary tumor stage (p=0.044) of lung cancer. Nuclear Atoh1 expression was positively correlated with nuclear expression of chibby (p<0.001) and Dab2 (p<0.001). Cytoplasmic Atoh1 expression was positively correlated with the cytoplasmic expression of Axin (p=0.028), chibby (p<0.001), and Dab2 (p<0.001). We conclude that the nuclear expression of Atoh1 was inversely correlated with the differentiation and primary tumor stage of lung cancers. The expression and localization of Atoh1 correlated with Axin, chibby, or Dab2. Atoh1 may be a potential therapeutic target for the inhibition of growth and progression of lung cancers.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 27 条
  • [21] Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression
    Cui, Nan
    Yang, Wen-Ting
    Zheng, Peng-Sheng
    ONCOTARGET, 2016, 7 (18) : 26152 - 26167
  • [22] BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors
    Dudnik, Elizabeth
    Peled, Nir
    Nechushtan, Hovav
    Wollner, Mira
    Onn, Amir
    Agbarya, Abed
    Moskovitz, Mor
    Keren, Shoshana
    Popovits-Hadari, Noa
    Urban, Damien
    Mishaeli, Moshe
    Zer, Alona
    Allen, Aaron M.
    Rabinovich, Natalie Maimon
    Rotem, Ofer
    Kuznetsov, Teodor
    Shochat, Tzippy
    Roisman, Laila C.
    Bar, Jair
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : 1128 - 1137
  • [23] Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway
    Zhu, Weiliang
    Shi, Lin
    Gong, Yuxin
    Zhuo, Lin
    Wang, Siyun
    Chen, Shaobing
    Zhang, Bei
    Ke, Bin
    THORACIC CANCER, 2022, 13 (07) : 1027 - 1039
  • [24] Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer
    Sumitomo, Ryota
    Huang, Cheng-Long
    Fujita, Masaaki
    Cho, Hiroyuki
    Date, Hiroshi
    ONCOLOGY REPORTS, 2022, 47 (04)
  • [25] Protein Kinase D1 Is Increased in Tumor Tissue, Correlates With Advanced Tumor Features and Worse Prognosis of Non-Small Cell Lung Cancer (Publication with Expression of Concern. See vol. 22, 2023)
    Yao, Jing
    Jiang, Yan
    Geng, Shuang
    Sun, Li
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [26] Tumor-associated inflammatory microenvironment in non-small cell lung cancer: correlation with FGFR1 and TLR4 expression via PI3K/Akt pathway
    Zhang, Ruhui
    Dong, Yongquan
    Sun, Mingjiao
    Wang, Yina
    Cai, Changqing
    Zeng, Yun
    Wu, Yueguang
    Zhao, Qiong
    JOURNAL OF CANCER, 2019, 10 (04): : 1004 - 1012
  • [27] Predicting immunotherapy-related adverse events in late-stage non-small cell lung cancer with KARS G12C mutation treated with PD-1 inhibitors through combined assessment of LCP1 and ADPGK expression levels
    Chen, Lei
    Xu, Cong
    Ren, Weihao
    Yu, Lei
    Tang, Tian
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (10): : 4803 - 4816